NeuroVoices
Every Wednesday, NeurologyLive®'s NeuroVoices series features in-depth, exclusive conversations with a wide variety of experts in the care and management of patients with neurologic diseases about a range of topics in clinical care and therapeutic development.
NeuroVoices: Michael Sughrue, MD, on Using Machine Learning to Build a Better Brain Map
June 1st 2022The founder and chief medical officer of Omniscient Neurotechnology discussed how the use of machine learning and big data will be critical in revolutionizing our understanding of the brain and mental illnesses.
NeuroVoices: Michael Sughrue, MD, on the Future of Brain Mapping and Utilizing Advanced Technology
May 25th 2022The founder and chief medical officer of Omniscient Neurotechnology provided commentary on expanding the brain map, the use of advanced technology, and the need to familiarize clinicians with connectomics.
NeuroVoices: Mark Lew, MD, on Exploring Reflex Tears as a Biomarker for Parkinson Disease
April 27th 2022The director of the Division of Movement Disorders at the USC Keck School of Medicine discussed the phenomenon behind reflex tears and whether they can serve as a valuable biomarker for Parkinson disease.
NeuroVoices: Neal Hermanowicz, MD, on Isolation’s Impact on Patient Burden in Parkinson Disease
April 20th 2022The neurologist at Christus St Vincent Health System discussed a recently conducted survey on the effects of social isolation and the need to keep patients with Parkinson disease socially connected.
NeuroVoices: Elia Pestana-Knight, MD, on the Importance of Ganaxolone’s Approval in CDD
April 6th 2022The pediatric epileptologist at Cleveland Clinic’s Epilepsy Center discussed data presented at AAN 2022 on the use of ganaxolone in CDD, as well as how its recent approval sets the stage for the future.
NeuroVoices: Jiwon Oh, MD, PhD, on Radiologically Isolated Syndrome as a Precursor to MS
March 9th 2022The staff neurologist and medical director of the Barlo Multiple Sclerosis Program at St Michaels Hospital provided insight on the use of biomarkers to improve management of RIS and uncover more as it relates to MS.
NeuroVoices: Imad Najm, MD, on Aiming to Prevent Neurological Disorders Before Symptom Onset
February 9th 2022The director of Cleveland Clinic’s Epilepsy Center discussed the new Cleveland Clinic Brain Study, which will evaluate predisease fingerprints from patients who go on to develop neurological disorders.
NeuroVoices: Joanna Hellmuth, MD, MS, on COVID-19 Pathogenesis and Long-Term Cognitive Changes
February 2nd 2022The cognitive neurologist at the University of California, San Francisco provided insight on the research needed to explain more about COVID-19’s pathogenesis and the realistic possibility of developing neurocognitive disorders.
NeuroVoices: Joanna Hellmuth, MD, MS, on Recognizing, Characterizing Post-COVID Cognitive Changes
January 26th 2022The cognitive neurologist at the University of California, San Francisco discussed recently published data on the presence of cognitive post-acute sequelae of COVID-19 and the need to legitimize these conditions.
NeuroVoices: Irene Wang, PhD, on the Clinical Utility of MR Fingerprinting in Epilepsy
January 12th 2022The research director and staff scientist at Cleveland Clinic’s Epilepsy Center discussed why MR fingerprinting holds significant clinical potential in epilepsy and epilepsy-related disorders.
NeuroVoices: Anne-Maree Kelly, MD, on Evaluating and Improving Care for Migraine in the ED
December 29th 2021The director of the Joseph Epstein Center for Emergency Medicine Research provided context on a study that showed wide variation in EDs diagnosis, treatment, and management of headache.
NeuroVoices: Jessica Fesler, MD, MEd, on the Need to Improve and Integrate Seizure Tracking Apps
December 8th 2021The staff epileptologist at Cleveland Clinic’s Epilepsy Center discussed the current state of seizure tracking applications, their limitations, and their untapped potential to be integrated in clinical care and with electronic medical records.
NeuroVoices: Orrin Devinsky, MD, on Unanswered Questions With SUDEP, Heart Rate Variability
November 24th 2021The director of the Comprehensive Epilepsy Center at NYU Langone discussed the large-scale impact heart rate variability has on preventing SUDEP and the unanswered questions that remain.
NeuroVoices: Alexander Merkler, MD, MS, on Anticoagulants for Stroke and Ventricular Dysfunction
November 10th 2021The assistant professor of neurology at Weill Cornell Medicine provided thoughts on his exploratory analysis, which found rivaroxaban to be superior to aspirin in reducing recurrent stroke.
NeuroVoices: Le Hua, MD, on Siponimod’s Efficacy Regardless of Age
November 3rd 2021The director of the Multiple Sclerosis Program at Cleveland Clinic’s Lou Ruvo Center for Brain Health provided context on the EXPAND study, which evaluated treatment efficacy and safety in older and younger patients on siponimod (Mayzent; Novartis).
NeuroVoices: Ilya Kister, MD, on Understanding Long-Term Responses to Vaccines in MS
October 27th 2021The professor of neurology at the NYU Grossman School of Medicine provided his thoughts on the VIOLA study and the importance of monitoring cell response of post-vaccinated patients with MS on DMTs.
NeuroVoices: David R. Lynch, MD, PhD, on the First Potentially Approved Friedreich Ataxia Treatment
September 29th 2021The professor of neurology at the University of Pennsylvania Perelman School of Medicine discussed the state of care for Friedrich ataxia and omaveloxolone’s potential to become its first approved therapy.
